Literature DB >> 28660635

Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.

Michael Benzaquen1, Jilliana Monnier1, Yasmine Beaussault1, Frank Rouby2, Philippe Berbis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28660635     DOI： 10.1111/ajd.12545

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  4 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab.

Authors:  Amy J Petty; Melodi J Whitley; Alexandra Balaban; Kenneth Ellington; Anne L Marano
Journal:  JAAD Case Rep       Date:  2020-06-16

Review 3.  Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Authors:  Sahil Rawal; Sara Kianian; William Guo; Jocellie Marquez; Marissa Ayasse; Katherine A Siamas; Yoojin Lee; Joann Salvemini
Journal:  Arch Dermatol Res       Date:  2021-06-22       Impact factor: 3.017

Review 4.  Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature.

Authors:  Aleksandra Opalińska; Dominika Kwiatkowska; Adrian Burdacki; Mirosław Markiewicz; Dominik Samotij; Marek Dudziński; Jadwiga Niemiec-Dudek; Elżbieta Ostańska; Adam Reich
Journal:  Dermatol Ther (Heidelb)       Date:  2021-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.